GR3017369T3 - Use of heterocyclic derivatives in the treatment of cognitive disorders. - Google Patents
Use of heterocyclic derivatives in the treatment of cognitive disorders.Info
- Publication number
- GR3017369T3 GR3017369T3 GR950402486T GR950402486T GR3017369T3 GR 3017369 T3 GR3017369 T3 GR 3017369T3 GR 950402486 T GR950402486 T GR 950402486T GR 950402486 T GR950402486 T GR 950402486T GR 3017369 T3 GR3017369 T3 GR 3017369T3
- Authority
- GR
- Greece
- Prior art keywords
- treatment
- cognitive disorders
- heterocyclic derivatives
- attentional
- hydroxytryptamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868630077A GB8630077D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB868630074A GB8630074D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB868630076A GB8630076D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB878707175A GB8707175D0 (en) | 1987-03-25 | 1987-03-25 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3017369T3 true GR3017369T3 (en) | 1995-12-31 |
Family
ID=27449858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR950402486T GR3017369T3 (en) | 1986-12-17 | 1995-09-13 | Use of heterocyclic derivatives in the treatment of cognitive disorders. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4985437A (el) |
EP (3) | EP0551963A3 (el) |
JP (1) | JP2608079B2 (el) |
AT (2) | ATE152623T1 (el) |
DE (2) | DE3752062T2 (el) |
ES (1) | ES2074981T3 (el) |
GR (1) | GR3017369T3 (el) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2036587T5 (es) * | 1986-11-21 | 1995-10-16 | Glaxo Group Ltd | Medicamentos para el tratamiento o prevencion del sindrome de abstinencia. |
US5198447A (en) * | 1986-11-21 | 1993-03-30 | Glaxo Group Limited | Medicaments |
GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
WO1990014347A1 (en) * | 1989-05-24 | 1990-11-29 | Nippon Shinyaku Co., Ltd. | Indole derivatives and medicine |
US5171745A (en) * | 1990-07-13 | 1992-12-15 | Du Pont Merck Pharmaceutical Company | Method of treating neurological dysfunction using neutrotransmitter enhancers |
AU8405891A (en) * | 1990-08-31 | 1992-03-30 | Nippon Shinyaku Co. Ltd. | Indole derivative and medicine |
HU211081B (en) * | 1990-12-18 | 1995-10-30 | Sandoz Ag | Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same |
EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
IT1250629B (it) * | 1991-07-04 | 1995-04-21 | Boehringer Ingelheim Italia | Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. |
EP0688216A1 (en) * | 1993-03-08 | 1995-12-27 | Fujisawa Pharmaceutical Co., Ltd. | Medicament for treating or preventing cerebrovascular diseases |
GB9412995D0 (en) * | 1994-06-28 | 1994-10-26 | Prendergast Kenneth F | Safety enhancing pharmaceutical compositions of an active indazole |
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
AR036041A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
CA2460075A1 (en) * | 2001-09-12 | 2003-03-20 | Donn Gregory Wishka | Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases |
ES2383001T3 (es) | 2001-10-02 | 2012-06-15 | Pharmacia & Upjohn Company Llc | Compuestos de heteroarilo condensado sustituidos con azabicíclico para el tratamiento de enfermedades |
US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
EP1476448A2 (en) * | 2002-02-19 | 2004-11-17 | PHARMACIA & UPJOHN COMPANY | Azabicyclic compounds for the treatment of disease |
AU2003219690A1 (en) * | 2002-02-19 | 2003-09-09 | Pharmacia And Upjohn Company | Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease |
AU2003214936A1 (en) * | 2002-02-20 | 2003-09-09 | Pharmacia And Upjohn Company | Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
AU2003269401A1 (en) * | 2002-11-01 | 2004-05-25 | Pharmacia & Upjohn Company Llc | Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
GB201421161D0 (en) * | 2014-11-28 | 2015-01-14 | Ge Healthcare As | Metal complex formulations |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
JPS5936675A (ja) * | 1982-07-13 | 1984-02-28 | サンド・アクチエンゲゼルシヤフト | 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド |
DE3445377A1 (de) * | 1983-12-23 | 1985-07-04 | Sandoz-Patent-GmbH, 7850 Lörrach | Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen |
ATE86110T1 (de) * | 1984-12-20 | 1993-03-15 | Sandoz Ag | Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten. |
CH667657A5 (de) * | 1985-01-07 | 1988-10-31 | Sandoz Ag | Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine. |
US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
EP0405617A3 (en) * | 1985-03-14 | 1992-11-25 | Beecham Group P.L.C. | Medicaments for the treatment of anxiety |
US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
DE3687080T2 (de) * | 1985-04-27 | 1993-03-25 | Beecham Group Plc | Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung. |
DE3687980T2 (de) * | 1986-01-07 | 1993-06-17 | Beecham Group Plc | Indolderivate mit einer azabicyclischen seitenkette, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zusammensetzungen. |
HU202108B (en) * | 1986-07-30 | 1991-02-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol |
DE3801659A1 (de) * | 1988-01-21 | 1989-07-27 | Boehringer Ingelheim Kg | Tetrahydropyridin - derivate |
CA1332151C (en) * | 1988-01-28 | 1994-09-27 | Roman Amrein | Use of a benzamide to treat cognitive disorder |
EP0342558B1 (en) * | 1988-05-16 | 1994-02-02 | G.D. Searle & Co. | 2-amino-4,5-methyleneadipic acid compounds for treatment of CNS disorders |
YU150489A (sh) * | 1989-08-10 | 1992-12-21 | W.L. Gore & Co. Gmbh. | Uređaj za ispitivanje odevnih predmeta na nepromočivost |
AU647754B2 (en) * | 1989-10-16 | 1994-03-31 | Hem Research, Inc. | Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
ATE108448T1 (de) * | 1990-05-11 | 1994-07-15 | Sankyo Co | Piperdinyloxy- und chinindidinyloxy- isoxazol- derivate, ihre herstellung und ihre therapeutische verwendung. |
-
1987
- 1987-12-16 US US07/133,885 patent/US4985437A/en not_active Expired - Lifetime
- 1987-12-16 DE DE3752062T patent/DE3752062T2/de not_active Expired - Lifetime
- 1987-12-16 EP EP19930200775 patent/EP0551963A3/en not_active Withdrawn
- 1987-12-16 DE DE3751404T patent/DE3751404T2/de not_active Expired - Lifetime
- 1987-12-16 JP JP62318458A patent/JP2608079B2/ja not_active Expired - Lifetime
- 1987-12-16 AT AT93201171T patent/ATE152623T1/de not_active IP Right Cessation
- 1987-12-16 ES ES87311079T patent/ES2074981T3/es not_active Expired - Lifetime
- 1987-12-16 EP EP87311079A patent/EP0279990B1/en not_active Expired - Lifetime
- 1987-12-16 AT AT87311079T patent/ATE124865T1/de not_active IP Right Cessation
- 1987-12-16 EP EP93201171A patent/EP0559297B1/en not_active Expired - Lifetime
-
1995
- 1995-09-13 GR GR950402486T patent/GR3017369T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3751404D1 (de) | 1995-08-17 |
DE3752062T2 (de) | 1997-09-11 |
ATE152623T1 (de) | 1997-05-15 |
EP0551963A3 (en) | 1993-09-01 |
ES2074981T3 (es) | 1995-10-01 |
EP0559297B1 (en) | 1997-05-07 |
DE3751404T2 (de) | 1995-12-21 |
DE3752062D1 (de) | 1997-06-12 |
EP0559297A1 (en) | 1993-09-08 |
EP0279990B1 (en) | 1995-07-12 |
EP0279990A3 (en) | 1990-11-28 |
JP2608079B2 (ja) | 1997-05-07 |
US4985437A (en) | 1991-01-15 |
JPS63277623A (ja) | 1988-11-15 |
ATE124865T1 (de) | 1995-07-15 |
EP0551963A2 (en) | 1993-07-21 |
EP0279990A2 (en) | 1988-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0279990A3 (en) | Use of heterocyclic derivatives in the treatment of cognitive disorders | |
EA199700156A1 (ru) | Производные индола как антагонисты рецептора 5-нт | |
ES2174836T3 (es) | Heterrociclos nitrogenados triciclicos condesados como antagonistas de receptor de la sustancia p. | |
FI931370A (fi) | Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring | |
MY105438A (en) | 3-aminopiperidine derivatives and related nitrogen containing heterocycles. | |
DE69106365T2 (de) | Chinuclidinderivate. | |
NZ329627A (en) | 8-Heterocyclically substituted 1,3,8-triaza-spiro[4.5]decan-4-ones | |
EP0229444A3 (en) | Medicaments for the treatment of anxiety | |
GR3019490T3 (en) | Substituted piperazines as central nervous system agents | |
EP0176035A3 (en) | 1-substituted tetralin derivatives, their preparation and use | |
ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
ATE182467T1 (de) | Verwendung von antagonisten oder partiellen agonisten am 5-ht 1a-rezeptor zur behandlung und prävention von kognitiven störungen | |
MY107354A (en) | Substituted cyclohexenes as central nervous system agents | |
BG103089A (en) | Indoline derivatives useful as 5-ht-2c-receptor antagonists | |
EP0272876A3 (en) | Use of heterocyclic derivatives for the manufacture of medicaments | |
TNSN87003A1 (fr) | Pyrrolo (1,2-a)(4,1) benzoxazepines, procedes pour leur preparation | |
ES8502103A1 (es) | Procedimiento para la obtencion de amidas del acido piperazin-1-il-acetico substituido | |
GR3002829T3 (en) | 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction iii inhibiting properties and/or renal vasodilating properties | |
NO20012538D0 (no) | Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet | |
EP0330468A3 (en) | Use of heterocyclic derivatives as kappa-opioid receptor agonists in the treatment of cerebral ischaemia | |
ES1037548U (es) | Tapa extraible para waters y bidets. |